23andMe links DNA to medical records
- 23andMe said on May 20 it will partner with HealthEx so customers can import medical records and combine them with DNA data. (statnews.com) - The most specific new product detail is a planned “23andMe Health Summary,” now in development for customers in the company’s beta-testing program. (statnews.com) - HealthEx says it provides consumer medical-record access, and the first rollout is tied to 23andMe Beta Testing Program participants. (markets.financialcontent.com)
23andMe said this week it will let customers import medical records into its consumer platform through a partnership with HealthEx, linking clinical history with users’ genetic profiles in one product. The company described the move as a way to give customers a “360-degree view” of their health and said the feature will feed a new “23andMe Health Summary” now in development. (statnews.com) STAT reported the announcement was made Tuesday, May 19, at the STAT Breakthrough Summit West, and a GlobeNewswire release dated May 20 said the first version will be available to some users in the 23andMe Beta Testing Program. ### What exactly is 23andMe adding? The new feature is an import layer for medical records. 23andMe said members will be able to connect medical records to their genetic profiles, combining DNA data with clinical information inside the company’s consumer platform. (markets.financialcontent.com) The product is being framed around a single profile that pulls together genetics and records rather than keeping them separate. The May 20 announcement also says the in-development health summary will incorporate genetics, medical records, labs and lifestyle data into personalized recommendations. That broader description appeared in syndicated versions of the GlobeNewswire release and goes beyond the initial summit-stage framing reported by STAT. (statnews.com) ### Who is HealthEx, and what role does it play? HealthEx is the outside partner providing the medical-record connection. On its website, HealthEx says it unifies records across places of care into a connected history and helps people manage and share medical information securely. In the 23andMe announcement, the company is described as a platform for consumer medical-record access. HealthEx has been building similar partnerships elsewhere. (statnews.com) Its press page lists deals with Salesforce, Microsoft, WHOOP, Epic-related initiatives and Anthropic, all centered on letting users connect or move medical records across systems. That places the 23andMe agreement inside a broader push by HealthEx to become a consumer-facing records layer for health applications. ### What did 23andMe say the point is? (manilatimes.net) Robin Smith, 23andMe’s head of product, said the company is “moving toward a world of dynamic disease risk predictions based on an individual’s most current health data,” according to STAT. Smith said the goal is to provide “better, more personalized insights” by bridging DNA and medical records. (healthex.io) The company’s own release uses similar language but adds a product claim: that users will get choice and control over sharing records through a consented process. HealthEx said the records can be shared in a “secure, transparent, and consented manner,” according to the release. (healthex.io) ### Why does this raise new privacy questions? The combination itself is the issue. Genetic data is already among the most sensitive categories of personal information, and linking it to diagnoses, medications, lab results and care history creates a richer profile than either dataset alone. STAT noted that the integration raises privacy and trust stakes because a more complete profile could increase misuse risks or the fallout from any breach. (statnews.com) 23andMe has faced scrutiny over data security before. A proposed class-action settlement tied to the company’s 2023 data breach was publicly advertised with a claim deadline in February 2026, according to a settlement tracker; that is not an official court source, but it reflects the continuing public attention around how the company handles sensitive user data. (markets.financialcontent.com) ### When will people actually see it? The first users named by 23andMe are participants in its beta-testing program. The company has not, in the materials reviewed, given a broader public launch date or pricing for the records-linked health summary. (statnews.com) The next concrete milestone is the beta rollout described in the May 20 release. Any wider release, additional product details or updated privacy terms would likely appear through 23andMe’s media center and HealthEx’s press page, where both companies have posted partnership announcements. (mediacenter.23andme.com) (financialcontent.com) (openclassactions.com)